Company performance
Add to research
Current Price
as of Apr 21, 2025$12.15
P/E Ratio
N/A
Market Cap
$1.61B
Description
Add to research
Centessa Pharmaceuticals Plc operates as clinical-stage pharmaceutical company, which engages in discovering and developing medicines that delivers transformational to patients. Its portfolio include preclinical to phase three uncorrelated programs spanning diseases with high unmet need across oncology, hematology, immunology, inflammation, neuroscience, and rare diseases. The company was founded on October 26, 2020 and is headquartered in Altrincham, the United Kingdom.
Metrics
Add to research
Overview
- HQAltrincham, CA
- SectorHealth Technology
- IndustryPharmaceuticals: Major
- TickerCNTA
- Price$12.15-1.18%
Trading Information
- Market cap$1.61B
- Float63.56%
- Average Daily Volume (1m)1,141,033
- Average Daily Volume (3m)1,044,562
- EPS-$2.06
Company
- RevenueN/A
- Rev growth (1yr)-100.00%
- Net income-$235.86M
- Gross marginN/A
- EBITDA marginN/A
- EBITDA-$200.20M
- EV$1.55B
- EV/RevenueN/A
- P/EN/A
- P/SN/A
- P/B4.01
- Debt/Equity29.19
Documents
Add to research
SEC Filings
Factset Street Account